UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

European heart journal, 2005-11, Vol.26 (21), p.2259-2268

2005

Volltextzugriff (PDF)

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

The American heart journal, 2005-02, Vol.149 (2), p.370-376

2005

Volltextzugriff (PDF)

9112 POSTER AVAPERL1 (MO22089) – Interim Safety of Maintenance (mtc) Bevacizumab (bev) + Pemetrexed (pern) in Patients (pts) With Advanced Non-squamous Non-small Cell Lung Cancer (nsNSCLC) After First-line (1L) Bev-cisplatin (cis)-pem Treatment (Tx)

European journal of cancer (1990), 2011, Vol.47, p.S626-S626

2011

Volltextzugriff (PDF)

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

The Lancet (British edition), 2003-07, Vol.362 (9377), p.7-13

2003

Volltextzugriff (PDF)

Exchange of β-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial)

European journal of heart failure, 2005-06, Vol.7 (4), p.640-649

2005

Volltextzugriff (PDF)

Bevacizumab (BEV) + Low-Dose Interferon-α2A (IFN) for First-Line Treatment of Metastatic Renal Cell Carcinoma (MRCC): Final Safety and Efficacy Data from the Prospective Bevlin Study

Annals of oncology, 2012-09, Vol.23, p.ix267

2012

Volltextzugriff (PDF)

3020 POSTER Preliminary efficacy of Bevacizumab with first-line Folfox, Xelox, Folfiri and fluoropyrimidines for mCRC: First BEAT trial

European journal of cancer supplements, 2007, Vol.5 (4), p.241-241

2007

Volltextzugriff (PDF)

The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild Heart failure evaluation trial (CARMEN)

Cardiovascular drugs and therapy, 2004, Vol.18 (1), p.57-66

2004

Volltextzugriff (PDF)

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)

European journal of heart failure, 2004-06, Vol.6 (4), p.467-475

2004

Volltextzugriff (PDF)

AVAPERL1 (MO22089): Maintenance (mtc) bevacizumab (bev) with or without pemetrexed (pem) in patients (pts) with advanced nonsquamous non-small cell lung cancer (nsNSCLC) treated with first-line (1L) bev-cisplatin (cis)-pem: Interim safety data

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7562-7562

2011

Volltextzugriff (PDF)

NEURO/MEDICAL ONCOLOGY

Neuro-oncology (Charlottesville, Va.), 2013-11, Vol.15 (suppl 3), p.iii98-iii135

2013

Volltextzugriff (PDF)

Preliminary efficacy of bevacizumab with first-line FOLFOX, XELOX, FOLFIRI and monotherapy for mCRC: First BEATrial

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.4072-4072

2007

Volltextzugriff (PDF)

Preliminary safety of bevacizumab with first-line Folfox, Capox, Folfiri and capecitabine for mCRC—First B.E.A.Trial

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3534-3534

2006

Volltextzugriff (PDF)

Feasibility of metastasectomy in patients treated with bevacizumab in first-line mCRC - Preliminary results from the First Beat-study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3523-3523

2006

Volltextzugriff (PDF)

Prognostic Impact of Symptoms in Chronic Heart Failure – Results from COMET

European Heart Journal, 2004

2004

Volltextzugriff (PDF)

Smoking deprivation in early and late smokers and memory functions

Psychopharmacologia, 1992-06, Vol.106 (2), p.253-260

1992

Volltextzugriff (PDF)

Relationship between gestational cocaine use and pregnancy outcome: A meta-analysis

Teratology (Philadelphia), 1991-10, Vol.44 (4), p.405-414

1991

Volltextzugriff (PDF)

179 Comparison of the effects of metoprolol and Carvedilol on symptoms, well-being and quality-adjusted life-years: a description of the "patient-journey" in COMET

European journal of heart failure. Supplements, 2004-06, Vol.3 (Suppl), p.37-37

2004

Volltextzugriff (PDF)

188 Incidence and type of adverse events occurring with carvedilol or metoprolol in the treatment of heart failure; results from COMET

European journal of heart failure. Supplements, 2004-06, Vol.3 (Suppl), p.40-40

2004

Volltextzugriff (PDF)

183 Carvedilol has a better protective effect against major vascular events than metoprolol in heart failure - Results from the COMET study

European journal of heart failure. Supplements, 2004-06, Vol.3 (Suppl), p.38-38

2004

Volltextzugriff (PDF)

184 Effect of long-term treatment with carvedilol compared to metoprolol on heart failure morbidity and diabetes in COMET

European journal of heart failure. Supplements, 2004-06, Vol.3 (Suppl), p.38-39

2004

Volltextzugriff (PDF)

187 Exchange of beta blocking therapy in heart failure patients. Experiences from the post study phase of COMET (The Carvedilol or Metoprolol European Trial)

European journal of heart failure. Supplements, 2004-06, Vol.3 (Suppl), p.39-40

2004

Volltextzugriff (PDF)

Relationship between gestational cocaine use and pregnancy outocme : a meta-analysis

Teratology (Philadelphia), 1991, Vol.44 (4), p.405-414

1991

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(22)
Tagungsberichte
(1)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

9112 POSTER AVAPERL1 (MO22089) – Interim Safety of Maintenance (mtc) Bevacizumab (bev) + Pemetrexed (pern) in Patients (pts) With Advanced Non-squamous Non-small Cell Lung Cancer (nsNSCLC) After First-line (1L) Bev-cisplatin (cis)-pem Treatment (Tx)

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Exchange of β-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial)

Bevacizumab (BEV) + Low-Dose Interferon-α2A (IFN) for First-Line Treatment of Metastatic Renal Cell Carcinoma (MRCC): Final Safety and Efficacy Data from the Prospective Bevlin Study

3020 POSTER Preliminary efficacy of Bevacizumab with first-line Folfox, Xelox, Folfiri and fluoropyrimidines for mCRC: First BEAT trial

The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild Heart failure evaluation trial (CARMEN)

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)

AVAPERL1 (MO22089): Maintenance (mtc) bevacizumab (bev) with or without pemetrexed (pem) in patients (pts) with advanced nonsquamous non-small cell lung cancer (nsNSCLC) treated with first-line (1L) bev-cisplatin (cis)-pem: Interim safety data

NEURO/MEDICAL ONCOLOGY

Preliminary efficacy of bevacizumab with first-line FOLFOX, XELOX, FOLFIRI and monotherapy for mCRC: First BEATrial

Preliminary safety of bevacizumab with first-line Folfox, Capox, Folfiri and capecitabine for mCRC—First B.E.A.Trial

Feasibility of metastasectomy in patients treated with bevacizumab in first-line mCRC - Preliminary results from the First Beat-study

Prognostic Impact of Symptoms in Chronic Heart Failure – Results from COMET

Smoking deprivation in early and late smokers and memory functions

Relationship between gestational cocaine use and pregnancy outcome: A meta-analysis

179 Comparison of the effects of metoprolol and Carvedilol on symptoms, well-being and quality-adjusted life-years: a description of the "patient-journey" in COMET

188 Incidence and type of adverse events occurring with carvedilol or metoprolol in the treatment of heart failure; results from COMET

183 Carvedilol has a better protective effect against major vascular events than metoprolol in heart failure - Results from the COMET study

184 Effect of long-term treatment with carvedilol compared to metoprolol on heart failure morbidity and diabetes in COMET

187 Exchange of beta blocking therapy in heart failure patients. Experiences from the post study phase of COMET (The Carvedilol or Metoprolol European Trial)

Relationship between gestational cocaine use and pregnancy outocme : a meta-analysis

Suchergebnisse filtern